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Abstract
Burmese is an old and popular cat breed, however, several health concerns, such as hypokalemia and a craniofacial defect,
are prevalent, endangering the general health of the breed. Hypokalemia, a subnormal serum potassium ion concentration
([K+]), most often occurs as a secondary problem but can occur as a primary problem, such as hypokalaemic periodic
paralysis in humans, and as feline hypokalaemic periodic polymyopathy primarily in Burmese. The most characteristic clinical
sign of hypokalemia in Burmese is a skeletal muscle weakness that is frequently episodic in nature, either generalized, or
sometimes localized to the cervical and thoracic limb girdle muscles. Burmese hypokalemia is suspected to be a single locus
autosomal recessive trait. A genome wide case-control study using the illumina Infinium Feline 63K iSelect DNA array was
performed using 35 cases and 25 controls from the Burmese breed that identified a locus on chromosome E1 associated
with hypokalemia. Within approximately 1.2 Mb of the highest associated SNP, two candidate genes were identified, KCNH4
and WNK4. Direct sequencing of the genes revealed a nonsense mutation, producing a premature stop codon within WNK4
(c.2899C.T), leading to a truncated protein that lacks the C-terminal coiled-coil domain and the highly conserved Akt1/SGK
phosphorylation site. All cases were homozygous for the mutation. Although the exact mechanism causing hypokalemia
has not been determined, extrapolation from the homologous human and mouse genes suggests the mechanism may
involve a potassium-losing nephropathy. A genetic test to screen for the genetic defect within the active breeding
population has been developed, which should lead to eradication of the mutation and improved general health within the
breed. Moreover, the identified mutation may help clarify the role of the protein in K+ regulation and the cat represents the
first animal model for WNK4-associated hypokalemia.
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Introduction
Potassium is the most abundant cation in mammals [1,2]. The
resting membrane potential of cells is affected by the relationship
between intracellular and extracellular potassium concentrations
and the resting potassium conductance [3]. Since the extracellular
potassium greatly affects the tendency of cells to fire action
potentials, potassium plays a crucial role in the function of nervous
tissue and muscle (skeletal, cardiac and smooth) throughout the
body [1,2], implying perturbations can be debilitating or even life-
threatening. To maintain ideal body homeostasis, potassium
excretion and dietary intake must be balanced [4–6]. Abnormal-
ities of potassium homeostasis can occur as a primary condition, or
as a secondary disorder [7–10]. Inherited hypokalemia has been
discovered in a variety of mammals by genetic studies of
individuals and families affected by clinical disease. A classic
syndrome of myopathic weakness, hyperkalemic periodic paralysis
(HYPP), has been defined genetically in humans [11–14] and
horses [15–18]. Genetic studies have shown that in humans, HYPP
is attributable to a channelopathy associated with abnormal
sodium conductance, usually inherited as an autosomal dominant
trait. Primary hypokalemic disorders have been documented in
humans, manifesting as episodic weakness associated with low
serum potassium [19].
Feline hypokalaemic periodic paralysis or Burmese hypokalaemic periodic
polymyopathy (BHP) has been recognized since the seminal cases
described by Blaxter and colleagues [20]. The disease is
characterized by muscle weakness associated with intermittent
hypokalemia [21]. Genetic studies suggest an autosomal recessive
condition in Burmese cats [20]. Blaxter [20] provided a full
description of the condition in the Burmese cat breed of the
United Kingdom, Jones and collaborators recorded similar
findings within Burmese cats from New Zealand [22], while
Mason and Lantinga documented the condition in cats in
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Australia and the Netherlands, respectively [23,24]. BHP has also
been diagnosed elsewhere in Europe [15], however the disease has
not been diagnosed within the Burmese cat population within the
United States.
Classically, signs of BHP are episodic but in some cats, the
weakness is incessant. During an episode, muscle pain (myalgia)
from palpation can be a prominent sign. Cats can present with
severe generalized muscle weakness, although more commonly
weakness of the cervical muscles as evidenced by ventroflexion of
the head and neck, head bobbing and dorsal protrusion of the
scapulae [20,23,25–27]. The gait becomes short and maximal
recruitment of motor units gives rise to muscle tremor. Cats with
more generalized weakness have a crouching gait, especially
evident in the hind limbs. Clinical signs of hypokalemia are
thought to develop once serum potassium concentrations decreas-
es below 3.0 mmol/l, although the rate with which the potassium
concentration decreases and the lowest concentration achieved
during an episode probably also influence the onset and the
severity of signs. Although the course of the disease is usually
affected by veterinary intervention, including potassium supple-
mentation, serum potassium usually spontaneously normalizes
after an episode. The disease usually becomes evident when kittens
are two to six months of age, although some cases have not been
detected until 2 years of age. Clinical signs may be triggered by
stress or exercise. In some patients, the condition improves
spontaneously or with therapy over a period of time, with some
cats eventually not requiring on-going medication. However, some
cats with BHP have life-time requirements for a potassium
supplementation.
A genome-wide association study (GWAS) using the illumina
Infinium feline 63K iSelect DNA array was performed on
hypokalemic and healthy Burmese to localize the gene responsible
for the hypokalemic periodic polymyopathy. A significant associ-
ation was identified on cat chromosome E1, which led to a
mutation discovery in WNK4. A genetic test has been developed
and carrier cats can be easily identified prior to mating, avoiding
the generation of affected cats. The WNK4 mutation in the
Burmese cat is linked for the first time with hypokalemia in a
mammalian species; a novel model for human disease.
Results
Clinical Presentation
Clinical presentation of cats diagnosed with hypokalemia
included: episodic or incessant musculoskeletal weakness frequent-
ly characteristically by ventroflexion of the head and neck
(Figure 1). Myopathic weakness was additionally associated with
a stiff/stilted gait, muscle tremor, head bobbing and dorsal
protrusion of one or both scapulae. Some cats were thought to
have myalgia on the basis of pain on muscle palpation or a shifting
lameness, which resolved with oral potassium supplementation. In
some cats, a weaving or a crouching gait, hypermetric forelimbs, a
wide-based hind-limb stance were also observed.
Most cats were diagnosed when young adults, between two and
six months of age, although occasional cats were diagnosed at a
later age. Although all cats considered as having hypokalemia had
reduced [K+] (by definition) at some point in time, this was not
always a consistent finding in affected cats, and sometimes it was
necessary to collect sequential blood samples to identify the time
when cats were unequivocally hypokalemic. Suggestive signs in
Burmese cats and sometimes increased serum CK or aspartate
aminotransferase (AST) activities were helpful in focusing the
clinicians’ attention on the possibility of a myopathy. The
demonstration of overt hypokalemia was further substantiated by
demonstrating an improvement in muscle strength after oral
potassium supplementation with potassium gluconate or chloride,
with a concurrent return of serum muscle enzyme activities to the
reference range.
Genome-wide Association Study
The affected Burmese cats originated from Australia, UK and
Germany (samples from both countries were grouped in the
Europe category), therefore unaffected, control cats were selected
from the same countries with an established minimal relationship
to the cases (Table 1). Seventy-two cats, including 38 cases (36
Burmese and 2 random bred cats) and 34 controls, were submitted
for SNP array genotyping. Ten cats, including 1 case and 9
controls, had genotyping rates ,90% and were excluded from
analysis, but included in the cohort of samples that were
genotyped for the identified mutation (Table 1). Testing for
stratification by MDS revealed that the cats were not in one
genetic cluster (Figure 2a). Even though the distribution of the
cases and controls was not equally dense across the cluster, only
two obvious affected outliers, the random bred cats, were
identified and excluded from the analysis, thus the final number
of cases included in the analyses was 35 Burmese. Additionally, 10
cases from the same geographical region, European Burmese, did
not group together within the cluster (Figure 2b). Twelve samples
had a P^w0:3 and the two random bred samples had a P^~0:5
suggesting that the two samples are sibs. The detected genomic
inflation factor (l ) was 1.8 (Figure 2c). To reduce l, several case-
control studies were conducted after several samples pruning
(Figure S1). The sample size range from 26–50 while the p-value
varies from 7.2261025–1.6661029. The highest l is detected
when none of the Burmese samples is excluded from the analyses.
The lowest l=1.09 is detected when the most genetically similar
control is selected for each case (Table S2).
After evaluating the genotype qualities of the 62,897 SNPs on
the array, 34,800 markers passed quality control, 27,152 SNPs had
a MAF ,5% and 1206 SNPs a GENO value .0.1. By analyzing
35 cases and 25 controls, a significant association was identified
with several SNPs on chromosome E1 (Figure 3), with the most
significant association for a SNP at position 73,054,644 (the Whole
Genome Shotgun project has been deposited at DDBJ/EML/
GenBank under the accession AANG00000000. The sequence
assembly used in this study is the second version,
AANG02000000). A second association was detected with
chromosome C2 with a SNP at position 5,583,090 (Table S2).
After correcting Praw values for multiple hypotheses testing by
permutation, six SNPs on chromosome E1 reached genome wide
significance (Pgenome = 0.00002 for SNP E1 at position 73,054,644)
and one less significant SNP on chromosome C2 position
5,583,090 (Pgenome = 0.046) (Figure S1). The strongest association
on chromosome E1 was detected within a region between
chromosome positions ,72 to 73 Mb. A haplotype block was
identified from position 73,054,644 to position 74,507,499 with a
frequency of 75.7% across all cases, suggesting the most likely
region associated with the disease (Figure S3). Within the same
block, controls showed a 16.6% haplotype frequency. The two
affected random bred samples excluded from the case-control
study, showed a different haplotype compared to the affected
Burmese cats. Inspection of genes within this haplotype block
revealed two strong candidates involved in potassium level
regulation, KCNH4 at ,570 Kb and WNK4 at ,1.2 Mb from
the SNP with the highest association (Figure S4). The location of
the two genes compared to the SNP position is presented in Figure
S4. Since WNK4 is not annotated in the Felis catus genome, the
distance between the two genes (KCNH4 and WNK4) in the human
Hypokalemia in Cats Associated with WNK4 Mutation
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genome was used to infer the distance between the same genes in
the cat assembly.
KCNH4 and WNK4 Analyses
A partial KCNH4 (GenBank accession no. JQ522970) coding
sequence (CDS), which was missing exons 1 and 13, was analyzed
in four unrelated Burmese cats (two cases and two controls) and
one random bred cat. Four variants were identified across the
CDS and none were concordant with the phenotype (Table S3).
Polymorphisms identified in the intronic sequence are reported in
Table S3.
The entire CDS of WNK4 (GenBank accession no. JQ522971),
including partial 59 UTR and the 39 UTR, was analyzed in the
same four Burmese (2 cases and 2 controls) and a control random
bred cat. In humans, WNK4 has one isoform and the length of the
coding region within the transcript is 3,732 bp. In the cat, WNK4
has 19 exons, the boundaries were confirmed by genomic
sequencing of the five cats used for the analyses of KCNH4,
producing a 3,711 bp CDS that translates into 1236 amino acids.
The differences between the two transcripts are located in exon 1
(3 bp), exon 13 (3 bp) and exon 14 (12 bp+3 bp). The average
CDS identity between human and cat is 89.3% and at the protein
level WNK4 is 90% identical to human. Three of the four
identified exonic polymorphisms are missense mutations (Table 2),
the affected cats showed an AGTC haplotype and the controls an
AGCT haplotype at the mutated positions. The first (c.340G.A)
and second (c.2851G.A) result in alanine to threonine substitu-
tions, the third mutation (c.2899C.T) causes a premature stop
codon (CAG.TAG). Moreover, the mutation is validated by the
RNA transcript sequence obtained from the affected Burmese cat
blood. This mutation responsible for a premature WNK4 protein
truncation lacking the C-terminal coiled coil domain and the
Akt1/SGK phosphorylation site was further investigated. Several
variants identified in the intronic regions (Table 2) were highly
variable and were not concordant with the disease phenotype in
the cats analyzed.
WNK4 Genotyping Analyses
A multi-generational pedigree consisting of 35 cats, segregating
for hypokalemia (Figure 4), was genotyped for eight STRs [28].
Figure 1. Phenotypes of Burmese cats and Burmese affected with hypokalemia. a. Unaffected Burmese of champagne coloration, b.
hypokalemia affected Burmese of red coloration, displaying ventroflexion of the head and neck.
doi:10.1371/journal.pone.0053173.g001
Figure 2. Multi-dimensional scaling and QQ-plot of Burmese cats analyzed for hypokalemia. a. Multi-dimensional scaling showing the
distribution in 2 dimensions of the cases and controls of Burmese cats. The black asterisk indicates the location of the two random bred cat outliers
excluded from the association analyses. b. Multi-dimensional scaling showing the differences between the geographical origins of the cats included
in the analyses. The black asterisk indicates the 10 European Burmese cases that did not cluster with the majority of the Burmese samples included in
the study. c. Q–Q plot showing an inflation in the test statistics with a l= 1.8.
doi:10.1371/journal.pone.0053173.g002
Hypokalemia in Cats Associated with WNK4 Mutation
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All the relationships between cats were confirmed as reported
(data not show). Nine affected cats, with either carrier or affected
parents, were confirmed by genotyping as homozygous for the
c.2899C.T mutation. Of the 26 unaffected cats, ten were
homozygous wildtype and 16 were carriers.
All the unaffected cats from other USA breeds (Bombay and
Tonkinese), as well as random bred cats, were homozygous
wildtype (n = 33). Fifty Burmese cats from Asia, Australia and
Europe (Germany and UK), including 34 GWAS affected and 16
unaffected cats, with available potassium concentrations were
genotyped and all the affected cats were homozygous for the
c.2899C.T mutation; the unaffected individuals were either
carriers or homozygous wildtype (Table 1).
A cohort of 268 cats from different breeds including Asian,
Australian Mist, Burmese, Burmilla, Tiffanie and 2 unknown cats
was used to estimate the disease allele frequency. The frequency of
the affected allele within the population is estimated as 14.9%
(Table S4).
Discussion
Variations in the flux and balance of several ions, such as K+,
Ca2+, Na+, and Cl2 play key roles in specific tissue functions. In
skeletal muscle, perturbations of these electrolytes are responsible
for periodic paralyses, paramyotonia, and myotonia [1,29].
Periodic paralyses constitute a group of hereditary muscle
disorders characterized by acute and reversible attacks of muscle
weakness associated with decrease blood pressure [30] in humans
and is reported in other species such as, cow [31], horse [32,33],
rat and dog [34,35]. Hypokalemic periodic paralysis is the most
frequent form of periodic paralysis in humans, with an estimated
prevalence of 1/100,000 [36]. Death due to paralysis of
respiratory muscles [37] or from cardiac arrhythmia, secondary
to a severe decrease in blood potassium concentration has been
reported [38].
This case-control genome-wide association study was performed
on a cohort comprising of 35 cases and 25 controls from the
Burmese breed. Although the disease is usually episodic, definitive
diagnosis can be made by the clinical presentations. Polymyopathy
was reported in the domestic cat in 1983 [25] and hypokalemic
periodic paralysis in the Burmese breed was first reported the UK
and later identified in Australia and New Zealand
[20,22,25,26,39]. However, Burmese cats in the USA have not
been reported with hypokalemia. Due to differences in breed
standards and health concerns, the Burmese in the USA are
generally isolated from the Burmese in other countries. For the
non-American-derived Burmese, diseases endangering the general
health of the breed are hypokalemia [20,25], diabetes mellitus [40]
and an orofacial pain syndrome [41,42]. The American-derived
Burmese are highly associated with a craniofacial defect [43] and
flat-chested kitten syndrome [44] is found in both breed
populations. Amongst cat breeds, both the USA and non-USA
Table 1. Domestic cats genotyped for the mutation
associated with hypokalemia.
Breed Origin Phenotype No. Genotype
C/C C/T T/T
USA Normal 16 16 0 0
Asia Affected* 2 0 0 2
Burmese Europe (UK Affected*+ 22 0 0 22
+ Germany) Normal+ 16 10 6 0
Australia Affected* 8 0 0 8
Normal 0 0 0 0
Random Bred UK Affected* 2 0 0 2
Pedigree Europe Affected* 9 0 0 9
Normal** 26 10 16 0
Bombay USA Normal 13 13 0 0
Random Bred USA Normal+ 10 10 0 0
Tonkinese USA Normal 10 10 0 0
Total 134
*All available affected cats were used in GWAS except only four of nine cats in
the pedigree (Figure 2).
**From the pedigree, only two of 26 cats were selected for the study (Figure 2).
+Cats used for sequencing: two affected, two controls, one random bred.
doi:10.1371/journal.pone.0053173.t001
Figure 3. Manhattan plot summarizing the case – control GWAS for Burmese cats with hypokalemia. The associated SNPs from 72 to
73 Mb on cat chromosome E1 (chromosome 14) obtained by analyzing 35 cases and 25 controls, correspond to a region containing the two
candidate genes, KCNH4 at ,570 Kb and WNK4 at ,1.2 Mb from the SNP with the highest association (E1.73054644, P raw= 9.274610212
uncorrected).
doi:10.1371/journal.pone.0053173.g003
Hypokalemia in Cats Associated with WNK4 Mutation
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Burmese populations present the highest linkage disequilibrium
within cats (data not shown), likely due to geographical isolations
and population bottlenecks. Due to these suspected population
differences, USA-derived Burmese were not used as controls. In
addition, 27,152 SNPs (43.1%) were excluded from the analysis
due to MAFs ,0.05, suggesting low genetic diversity in the breed,
which was previously suggested by microsatellite analyses [45]. All
the non-American Burmese clustered to some extent, indicating
that some population sub-structure is present, which was
supported by a genomic inflation factor of 1.8. The genomic
inflation was reduced after each sample pruning, and got as low as
1.09 after excluding 34 samples. However, the lower samples size
reduces power in detecting the association. When the samples size
drops as low as 34, the SNP previously detecting the association is
no longer the most significant association and the regional
candidate would not be identified. To reduce genomic inflation,
sib-pairs from a litter would be more ideal, however, as with most
disease ascertainment, cases were collected over a long period and
access to normal sibs or parents was not usually feasible.
The haplotype analysis of the 2.6 Mb region surrounding the
most significant SNP association identified a 1.45 Mb block, with
the most common haplotype having a frequency of .75% within
the cases and ,16% in the controls, supporting the region
containing KCNH4 and WNK4 as strongly associated with the
disease. The two related random bred cats were excluded from the
association analyses, both were outliers in the MDS analyses and
both had a completely different genetic background surrounding
the associated SNPs as determined by the haplotype analysis.
However, the random bred cats were homozygous for the
identified hypokalemia mutation in the Burmese breed suggesting
a mutation that precedes breed information. By fine mapping, a
common short haplotype block with the controls would probably
be identified.
Within ,1.45 Mb of the highest associated SNP, two viable
candidate genes, KCNH4 and WNK4, were identified. In KCNH4,
no polymorphisms were identified between cases and controls,
suggesting no differences between the affected and wild type
alleles. However, sequencing of KCNH4 was not completed, hence
the gene cannot be excluded as responsible for the disease.
Sequencing of the second candidate gene, WNK4 identified a
c.2899C.T nonsense mutation in the coding sequence. To
confirm the association of the c.2899C.T mutation with
phenotype, a multi-generational pedigree segregating for the
disease was genotyped. All the affected cats tested homozygous for
the premature stop codon, while the unaffected Burmese were
either wildtype or heterozygous, supporting the c.2899C.T
mutation as likely responsible for the disease. All identified cases
in the study were homozygous for the mutation, while control
Burmese were either heterozygous or wildtype. All available
parents of the affected cats were heterozygous for the identified
mutation. The genotyping was extended to a limited random bred
population from South Asian and other South Asian - derived
breeds, such as Bombay and Tonkinese, which use or have used
Burmese in their breeding programs. The mutation was not
identified within these cats. The initial estimate of the mutation
frequency within the non-USA derived Burmese population, as
well as in the breeds that use Burmese in outcross programs, is
14.9%. The frequency was obtained using data from a service
laboratory from cats submitted for hypokalemia genetic testing,
hence likely suspected to be at risk for disease, thus a positive bias
in the data is expected. The genetic test will greatly assist breeders
to avoid mating that could generate affected cats and identify
carrier cats that could be excluded from the breeding program.T
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Point mutations in WNK4 have been associated in humans with
the dominant disorder familial hyperkalemic hypertension and
characterized by dysfunction in renal Na+, K+, and Cl2
homeostasis [46–52]. Wilson et al. [50] originally identified
WNK4 as a serine-threonine protein kinase that is expressed
virtually exclusively in the kidney [53], localizing to the distal
convoluted tubule and the cortical collecting duct [54], adjacent
segments of the distal nephron that play a key role in salt, water,
potassium, and pH homeostasis [50]. WNK4 is a member of the
WNK kinases that have recently become a major focus of
investigation because they comprise a previously unrecognized
signaling pathway. The pathway appears to be essential for normal
development, regulation of arterial pressure, normal electrolyte
balance and for sensory nerve function, however the mechanisms
by which WNK kinases regulate these processes are poorly
understood [48,49].
The WNK4 gene in humans is 16 Kb, contains 19 exons [50]
and the protein is characterized by a kinase domain, an auto
inhibitory autophosphorylation domain that lies in close proximity
to the C-terminal end, two coiled-coils domains and proline-rich
sequences [46]. The truncated protein in affected Burmese lacks
the C-terminal coiled-coil domain, and is missing the highly
conserved Akt1/SGK phosphorylation site at position S1169 [54].
Wang et al [55] demonstrated that truncated WNK4 constructs
lacking the C terminus had no kinase activity toward themselves
(autophosphorylation), hence WNK4 is constantly active. Studies
suggest that when WNK4 is over-expressed, blood pressure is
lower and when challenged with a low potassium diet, serum K+ is
also reduced [56]. To date, studies of blood pressure in affected
Burmese cats with hypokalemia have not been undertaken; it
would therefore be informative to determine if cats are hypoten-
sive during episodes of hypokalemia. Morphological studies in
mice show that extra WNK4 copies reduced the abundance of the
thiazide-sensitive Na-Cl cotransporter (NCC) in the kidney cortex
[47,57,58]. The interaction between WNK4 and NCC, through its
kinase domain, is suggested to result in high lysosomal degradation
of NCC. When WNK4 is inhibited by autophosphorylation, NCC
transfers to the membrane and Na+ and Cl2 re-absorption activity
is initiated. The deranged physiology seen in cats with BHP may
be similar to the loss of function of NCC in humans [59] and mice
[60,61]. In hypokalemic cats, the WNK4 protein should be
constantly active since the autophosphorylation site is missing and
the protein constantly acts as an inhibitor for the NCC channel.
When the NCC channel is not present on the cell surface, sodium
gets reabsorbed by the epithelial channel (ENaC) [62], leaving a
lumen Cl2 negative potential that causes a secretion of K+ by the
ATP-sensitive epithelial K+ channel (ROMK) channel [63]. The
presumptive role of the C-terminal region of WNK in the cat can
be proven and elucidated by functional studies using truncated
transcripts in the future.
Materials and Methods
Animal Screening and Clinical Description
Thirty-eight cats with a diagnosis of hypokalemia were
ascertained (Table 1, Figure 1). Most cases were diagnosed by
the authors or by close colleagues; however, some were obtained
by solicitation and submitted by owners who had received a BHP
diagnosis for their cat from their primary care veterinarian.
Burmese cats were verified as having BHP based on consistent
Figure 4. Burmese cat pedigree segregating for hypokalemia. Circles represent females and squares represent males. Black symbols indicate
cats with classical clinical signs for hypokalemia, white symbols indicate healthy cats. The +/+, +/2, and 2/2 signs indicate cats that tested
homozygous wildtype, heterozygous, and homozygous affected for hypokalemia, respectively. Cats with a question mark in the symbol indicate that
the phenotypic data was not available; symbols with a diagonal line indicate that no DNA sample was available. The asterisk indicates the four
affected cats included in the GWA study, the number sign (#) indicate two of the controls used for the GWA study.
doi:10.1371/journal.pone.0053173.g004
Hypokalemia in Cats Associated with WNK4 Mutation
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clinical signs, seen in temporal association with serum potassium
less than 3.0 mmol/l, and usually in concert with elevated creatine
kinase (CK) activity in serum or plasma. Furthermore, all cats
suspected of having hypokalemic polymyopathy had an obvious
improvement in muscle strength with oral potassium supplemen-
tation (using potassium gluconate [4 mmol every 12 hours] or
potassium chloride [3.5 mmol every 12 hours]). Unaffected cats
(n = 34) had no clinical signs or owner/breeder reported evidence
for BHP. No IACUC approvals were obtained for this study since
samples were retained from patients as part of their primary care
for disease diagnosis. Standards of veterinary care appropriate for
an individual cat’s health and conditions were determined by the
primary care veterinarian.
Genotyping
Thirty-eight cases (36 Burmese and 2 random bred cats) and 34
controlBurmeseweresubmitted togenotypinganalysis.Wholeblood
samples were collected from affected cats as part of establishing their
clinical diagnoses. Buccal swabs were donated for some affected and
unaffected cats by Burmese breeders and owners. Moreover, a
pedigree of cats segregating for hypokalemia was developed from a
sub-set of submitted samples (four were included in the GWAS)
(Figure 4). Additional unaffected cats were selected from an
available database of non-USA origin/domiciled Burmese cats.
Genomic DNA was isolated from blood and buccal swab samples
using the DNAeasy Kit (Qiagen, Valencia, CA) and concentrated
using theGenomicDNAclean&ConcentratorKit (ZymoResearch,
Irvine, CA) when necessary. Quality and quantity of DNA was
confirmed by visualization with agarose gel electrophoresis and by
optical density using an UV exposure. Approximately 600 ng of
genomic DNA was submitted to Neogene, Inc. (Lincoln, NE, USA)
for genotyping on the illumina Infinium Feline 63K iSelect DNA
array (illumina, Inc., San Diego, CA).
Genome Wide Association Study
SNP genotyping rate and minor allele frequency (MAF) was
calculated using PLINK [64]. SNPs with a MAF ,5%,
genotyping rate ,90%, and individuals genotyped for ,90% of
SNPs were excluded from further analyses. A classic multi-
dimensional scaling (MDS) with 2 dimensions was performed on
56,811 SNPs in PLINK to evaluate population substructure within
cases and controls. Inflation of p-values was evaluated by
calculating the genomic inflation factor (l) and was assessed with
a quantile-quantile plot (Q-Q plot). A case-control association
analysis was performed and corrected with 50,000 t-max
permutations (-mperm 50,000). T-max permuted p-values were
considered genome-wide significant at p,0.05. A Manhattan plot
of the results was generated using HAPLOVIEW [65]. Linkage
disequilibrium (LD) and haplotypes were determined considering
SNPs from position 71,917,552 to position 74,507,499 of cat
chromosome E1 and presented as plots produced by HAPLO-
VIEW [65]. The P (proportion of identical by state – IBS) for each
individual was calculated using PLINK. To evaluate and reduce l
several strategies were applied, including, (i) exclusion of
individuals with a proportion of IBD .0.3, (ii) selection of samples
tightly clustered from the MDS plot and (iii) selection for each case
to the closest control using the values from the MDS dimensions
(Figure S1). After each correction, the number of cases and
controls included in each analysis, as well as the p-value of the
highest associated SNP, was evaluated and reported in Table S1.
KCNH4 Genomic Analyses
The genomic analyses of KCNH4 were conducted on genomic
DNA from five cats including two cases and two controls from the
Burmese breed and a random bred cat. Partial CDS of KCNH4 is
publicly available (http://ensembl.org) and can be found on
GeneScaffold_2463:456,252-473,070. Missing exonic sequence
was retrieved by aligning the individual human exons for KCNH4
(NM_012285.2) in the trace archive databases for Felis catus –
WGS (http://blast.ncbi.nlm.nih.gov). Primers were designed in
both UTRs and intronic regions, flanking the exons. Primers were
tested for efficient product amplification on a DNA Engine
Gradient Cycler (MJ Research, GMI, Ramsey, MN) and the final
PCR magnesium concentrations, annealing temperatures, and
amplicon sizes for each primer pair are shown in Table S5. PCR
and thermocycling conditions were conducted as previously
described [66]. The PCR products were purified with ExoSap
(USB, Cleveland, OH) per the manufacturer’s recommendations
and directly sequenced using the BigDye terminator Sequencing
Kit v3.1 (Applied Biosystems, Foster City, CA). Sequences were
verified and aligned using the software sequencer version 4.10
(Gene Codes Corp., Ann Arbor, MI).
WNK4 Genomic and mRNA Analyses
The genomic analysis of WNK4 was conducted as described for
KCNH4. WNK4 was not annotated in the available cat genome
assembly (Dec. 2008 NHGRI/GTB V17e/felCat4) and no
sequence was publicly available. The gene was identified by
comparison to the homologous region on human chromosome 17
corresponding to the associated cat region [67,68]. Cat exonic
sequences were retrieved from the cat trace archive using the
individual exons of human WNK4 (NM_032387.4). The final PCR
magnesium concentrations, annealing temperatures, and amplicon
sizes for each primer pair are shown in Table S5. The PCR cycle
was as follow: initial denaturation at 94uC for 4 min followed by
35 cycles as described: 94uC630 sec, 65uC630 sec, 72uC630 sec
and final extension at 72uC for 20 min.
Total RNA was extracted using the PAXgeneTM (Qiagen) from
whole blood from a control random bred cat and four affected
Burmese cats from the UK. Complementary DNA templates were
synthesized using SuperScript III (Invitrogen, Carlsband, CA) by
reverse transcription of 1 mg of total RNA with gene specific
primers (Table S5) and PolyT to obtain partial 59 UTR, CDS
and full 39 UTR. Each cDNA sample was subjected to PCR using
primers (10 mM each) combined as follow: 5utrF - 5utrR, F1 - R1,
F2 - R2, F3 - R3, F4 - R4, F5 - R5, F6 - R6, F7 - R7, F8 - polyT.
The PCR conditions were: 1.5 mM Mg, 2 ml of cDNA in a total
volume of 20 ml. The PCR cycle was: initial denaturation at 94uC
for 4 sec followed by a first set of 5 cycles at: 94uC630 sec,
70uC630 sec, 72uC630 sec, 5 additional cycles at: 94uC630 sec,
68uC630 sec, 72uC61 min and a set of 30 additional cycles at:
94uC630 sec, 68uC630 sec, 60uC61 min and a final extension at
72uC for 20 min. The PCR products with appropriate lengths
were purified using the ExoSap (USB) enzyme per manufacturer’s
recommendations. Purified genomic products were directly
sequenced in both directions using BigDye Terminator Sequenc-
ing Kit v3.1 (Applied Biosystems), purified with Illustra Sephadex
G-50 (Ge Healthcare, Piscataway, NJ) according to manufactur-
er’s recommendations and electrophoretically separated on an
ABI 3730 DNA analyzer (Applied Biosystems).
WNK4 Mutation Genotyping
To implicate the identified mutation as causative for hypoka-
lemia, a pedigree segregating for hypokalemia with 35 available
cats, was genotyped by direct sequencing (Figure 4). Relation-
ships within the pedigrees were confirmed with a published
microsatellite-based parentage panel available for the cat (data not
shown) [28]. Additional cats were also genotyped by direct
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sequencing to support correlation with disease, including 16 USA-
derived Burmese, 16 unrelated unaffected, 34 affected GWAS
Burmese (Asia, Europe, Australia), 2 affected random bred GWAS
cats, 10 Tonkinese, 13 Bombay and 10 random bred cats
(Table 1). Primers for the direct sequencing genotyping are
presented in Table S5.
Frequency Estimation
Owners submitted buccal swab samples of cats (n = 268) to
determine status of the hypokalemia mutation to Langford
Veterinary Services, UK (Table S4). Cats were genotyped for
the WNK4 mutation to establish the allele frequency in the
breeding population and to further confirm association with
disease. Briefly, DNA was isolated from buccal swabs as previously
described [69]. The WNK4 mutation was amplified by PCR;
12.5 ml 26 GoTaq PCR Master Mix (Promega, UK), 200 mM
each Hypo For and Rev primers (Table S5) and 2 ml gDNA in a
total volume of 25 ml using a Bio-Rad MJ Mini (Life Science,
Hertfordshire, UK) as described: 95uC for 2 min, 38 cycles of
95uC615 sec, 58uC630 sec by 35 cycles. Amplicons were
subjected to pyrosequencing using sequencing primer Hypo Seq
on a PyroMark Q24 (Qiagen) using Pyro Gold reagents as
described by the manufacturer.
Supporting Information
Figure S1 MDS plots illustrating the samples included
in each case-control association analyses of cats with
hypokalemia. MDS plots showing a. the distribution of all the
genotyped samples, b. the samples included in the case-control
after exclusion of the related Burmese cats (p_hat .0.3), c. the
distribution of tightly clustered Burmese samples, d. allowing
more diversity than the cluster illustrated in (c), e. the closest
control for each case, and f. the samples remaining after exclusion
of related Burmese and outliers.
(TIF)
Figure S2 Manhattan plot of Burmese GWAS for
hypokalemia. After correcting for multiple testing (50,000
permutations), five SNPs (four on chromosome E1 and one on
chromosome C2) retained significant association (p,0.05; stron-
gest SNP association, cat chromosome E1 position 73,054,644).
The dashed line indicates genome wide significance.
(TIF)
Figure S3 Haplotype analyses of cats in hypokalemia
GWAS. Presented is the area within ,2.5 Mb of the highest
associated SNP on chromosome E2 in the Burmese cases and
controls. a. Cases haplotype block of the region surrounding the
highest hit in the Burmese. b. From the highest hit, a block
extending for ,1.45 Mb (9 SNPs) was identified c. Cases
haplotype frequencies, the red rectangle indicates the haplotype
most frequently found within the affected cats. d. Controls
haplotype block of the same region surrounding the highest hit
within the cases. e. Figure representing the same block presented
in (b) within the controls. f. Controls haplotype frequency, the red
rectangle indicates the frequency across the controls of the most
common haplotype identified within all the cases.
(TIF)
Figure S4 Haplotype within the ,2.5 Mb on chromo-
some E1. ,2.5 Mb are represented across all cases, controls and
the two random bred cats excluded from the association study.
The SNP in green across all samples represents the highest
associated SNP with the disease. The orange bar represents the
haplotype block shown in supplementary figure 2b and the relative
position of the 2 candidate genes within the block is presented.
(PDF)
Table S1 Evaluation of improved design to reduce
genomic inflation (l) in Burmese hypokalemia.
(DOC)
Table S2 Details of seven highest associated SNPs for
Burmese hypokalemia GWAS.
(DOC)
Table S3 SNP analyses of KCNH4 in cats with and
without hypokalemia.
(DOC)
Table S4 Genotypes and frequencies of WNK4 SNP in
cats submitted for genetic testing.
(DOC)
Table S5 KCNH4 and WNK4 PCR primers for analysis
of hypokalemia in cats.
(DOC)
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